Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells

Carcinogenesis

Volumn 23, Issue 6, 2002, Pages 967-975

  Karan, Dev ^a   Kelly, David L ^b   Rizzino, Angie ^a,b   Lin, Ming Fong ^a,b   Batra, Surinder K ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE 2; CYCLINE; CYCLINE H; CYTOKINE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN GI; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE ISOENZYME 5; MACROPHAGE INHIBITORY CYTOKINE 1; MACROPHAGE MIGRATION INHIBITION FACTOR; MYC PROTEIN; PROSTATE SPECIFIC MEMBRANE ANTIGEN; PROTEIN C MYC PURINE BINDING TRANSCRIPTION FACTOR; RIBOSOME PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MALE; MOLECULAR GENETICS; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0036317452     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/23.6.967     Document Type: Article

References (72)

1. Androgen receptor gene and hormonal therapy failure of prostate cancer
2. Orchiectomy for advanced prostatic carcinoma. A reevaluation
3. Carcinoma of the prostate
4. Identification and temporal expression pattern of genes modulated during irreversible growth arrest and terminal differentiation in human melanoma cells
5. DNA microarray analyses of genes regulated during the differentiation of embryonic stem cells
6. GATA-3 is expressed in association with estrogen receptor in breast cancer
7. Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array
8. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray
9. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer
10. Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia
11. Application of the differential hybridization of Atlas Human expression arrays technique in the identification of differentially expressed genes in human glioblastoma multiforme tumor tissue
12. Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: A revelation by parallel gene expression profiling
13. Molecular classification of human carcinomas by use of gene expression signatures
14. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
15. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
16. Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray
17. Identification of differentially expressed genes in organ-confined prostate cancer by gene expression array
18. Delineation of prognostic biomarkers in prostate cancer
19. Human prostate cancer and benign prostatic hyperplasia: Molecular dissection by gene expression profiling
20. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer
21. Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines
22. LNCaP model of human prostatic carcinoma
23. Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model
24. Decreased androgen-responsive growth of human prostate cancer is associated with increased genetic alterations
25. Transfection of the human Muc 1 mucin gene into a poorly differentiated human pancreatic tumor cell line, Panc1: Integration, expression and ultrastructural changes
26. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray
27. Molecular mechanisms of androgen-independent growth of human prostate cancer LNCaP-AI cells
28. LNCaP progression model of human prostate cancer: Androgen-independence and osseous metastasis
29. Myc oncogenes: The enigmatic family
30. The role of c-myc in cellular growth control
31. Single strand DNA specificity analysis of human nucleoside diphosphate kinase B
32. Enhanced expression of the c-myc protooncogene in high-grade human prostate cancers
33. Expression of the c-myc protooncogene in human prostatic carcinoma and benign prostatic hyperplasia
34. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization
35. Plasma lactate dehydrogenase: A marker of disease activity in cryptogenic fibrosing alveolitis and extrinsic allergic alveolitis?
36. Characterization of the glycolysis in lactate dehydrogenase-A deficiency
37. c-Myc transactivation of LDH-A: Implications for tumor metabolism and growth
38. Cancer-associated lactate dehydrogenase is a tyrosylphosphorylated form of human LDH-A, skeletal muscle isoenzyme
39. Expression of human prostatic acid phosphatase and prostate specific antigen genes in neoplastic and benign tissues
40. Identification of LDH-ras p21 protein complex and expression of these genes in human ovarian cancer
41. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily
42. MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation
43. Cloning and characterization of a novel member of the transforming growth factor-beta/bone morphogenetic protein family
44. The propeptide of the transforming growth factor-beta superfamily member, macrophage inhibitory cytokine-1 (MIC-1), is a multifunctional domain that can facilitate protein folding and secretion
45. Macrophage migration inhibitory factor in the human prostate: Identification and immunocytochemical localization
46. Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcinoma metastases
47. Macrophage migration inhibitory factor in prostatic adenocarcinoma: Correlation with tumor grading and combination endocrine treatment-related changes
48. Regulation of the immune response by macrophage migration inhibitory factor: Biological and structural features
49. Macrophage migration inhibitory factor: A regulator of glucocorticoid activity with a critical role in inflammatory disease
50. Cell lines from the same cervical carcinoma but with different radiosensitivities exhibit different cDNA microarray patterns of gene expression
51. Alterations in guanine nucleotide regulatory protein expression and activity in human hepatocellular carcinoma
52. Catecholamine refractoriness and their mechanisms in cardiocirculatory shock and chronic heart failure
53. Constitutive activation of the Gs alpha protein-adenylate cyclase pathway may not be sufficient to generate toxic thyroid adenomas
54. Stimulation of human thyroid growth via the inhibitory guanine nucleotide binding (G) protein Gi: Constitutive expression of the G-protein alpha subunit Gi alpha-1 in autonomous adenoma
55. Cell cycle control of DNA replication
56. Active cyclin A-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas
57. Elevated expression of the ribosomal protein S2 gene in human tumors
58. Ubiquitin-ribosomal protein S27a gene overexpressed in human colorectal carcinoma is an early growth response gene
59. Increased expression of human ribosomal phosphoprotein P0 messenger RNA in hepatocellular carcinoma and colon carcinoma
60. Molecular cloning and sequence analysis of the human ribosomal protein S16
61. Identification of a human ribosomal protein mRNA with increased expression in colorectal tumours
62. High-level expression of the ribosomal protein L19 in human breast tumors that overexpress erbB-2
63. Molecular structure of human TFIIH
64. p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner
65. Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigen
66. Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases
67. Alternatively spliced variants of prostate-specific membrane antigen RNA: Ratio of expression as a potential measurement of progression
68. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: A study of 184 cases
69. Enhanced expression of prostate-specific membrane antigen gene in prostate cancer as revealed by in situ hybridization
70. Western blot assay for prostate-specific membrane antigen in serum of prostate cancer patients
71. Prostate-specific membrane antigen levels in sera from healthy men and patients with benign prostate hyperplasia or prostate cancer
72. Prostate specific membrane antigen (PSM) is expressed in various human tissues: Implication for the use of PSM reverse transcription polymerase chain reaction to detect hematogenous prostate cancer spread